All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Flexible Stenting Solutions (FSS; Eatontown, New Jersey) said the first two patients enrolled in its OPEN clinical trial have received treatment. The trial, which is both prospective and single-arm, will enroll up to 227 patients at as many as 40 clinical sites. (Medical Device Daily)